American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: DSM-5. American Psychiatric Publishing, Inc., Arlington, VA, US
Andrade C (2019) Oral ketamine for depression, 1: Pharmacologic considerations and clinical evidence. J Clin Psychiatry 80:19f12820
Asnis GM, Kohn SR, Henderson M, Brown NL (2004) SSRIs versus Non-SSRIs in Post-traumatic Stress Disorder. Drugs 64:383–404
Article CAS PubMed Google Scholar
Australian Bureau of Statistics (2020) -21) National Study of Mental Health and Wellbeing
Baker DG, Nievergelt CM, O’Connor DT (2012) Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 62:663–673
Article CAS PubMed Google Scholar
Bates D, Mächler M, Bolker B, Walker S (2015) Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw 67:1–48
Bathina S, Das UN (2015) Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci 11:1164–1178
Article CAS PubMed PubMed Central Google Scholar
Bech P, Olsen LR, Kjoller M, Rasmussen NK (2003) Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 12:85–91
Article PubMed PubMed Central Google Scholar
Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc: Ser B (Methodol) 57:289–300
Benjet C, Bromet E, Karam EG, Kessler RC, McLaughlin KA, Ruscio AM, Shahly V, Stein DJ, Petukhova M, Hill E, Alonso J, Atwoli L, Bunting B, Bruffaerts R, Caldas-de-Almeida JM, de Girolamo G, Florescu S, Gureje O, Huang Y, Lepine JP, Kawakami N, Kovess-Masfety V, Medina-Mora ME, Navarro-Mateu F, Piazza M, Posada-Villa J, Scott KM, Shalev A, Slade T, ten Have M, Torres Y, Viana MC, Zarkov Z, Koenen KC (2016) The epidemiology of traumatic event exposure worldwide: results from the World Mental Health Survey Consortium. Psychol Med 46:327–343
Article CAS PubMed Google Scholar
Berger W, Mendlowicz MV, Marques-Portella C, Kinrys G, Fontenelle LF, Marmar CR, Figueira I (2009) Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 33:169–180
Article CAS PubMed Google Scholar
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351–354
Article CAS PubMed Google Scholar
Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL (2015) The Posttraumatic Stress Disorder checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. J Trauma Stress 28:489–498
Bouhaddou N, Mabrouk M, Atifi F, Bouyahya A, Zaid Y (2024) The link between BDNF and platelets in neurological disorders. Heliyon 10:e39278
Can AT, Hermens DF, Dutton M, Gallay CC, Jensen E, Jones M, Scherman J, Beaudequin DA, Yang C, Schwenn PE, Lagopoulos J (2021) Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study. Transl Psychiatry 11:101
Article CAS PubMed PubMed Central Google Scholar
R Core Team (2024) R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/
Davis LL, Suris A, Lambert MT, Heimberg C, Petty F (1997) Post-traumatic stress disorder and serotonin: new directions for research and treatment. J Psychiatry Neurosci 22:318–326
CAS PubMed PubMed Central Google Scholar
de Vries LP, van de Weijer MP, Bartels M (2022) The human physiology of well-being: A systematic review on the association between neurotransmitters, hormones, inflammatory markers, the microbiome and well-being. Neurosci Biobehavioral Reviews 139:104733
Deyama S, Duman RS (2020) Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav 188:172837
Deyama S, Bang E, Kato T, Li XY, Duman RS (2019) Neurotrophic and antidepressant actions of brain-derived neurotrophic factor require vascular endothelial growth factor. Biol Psychiatry 86:143–152
Article CAS PubMed Google Scholar
Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A, Biernacka JM, Abo R, Brisbin A, Ji Y, Hebbring S, Wieben ED, Mrazek DA, Weinshilboum RM, Wang L (2013) FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogenet Genomics 23:156–166
Article CAS PubMed PubMed Central Google Scholar
Green B (2013) Post-traumatic stress disorder: New directions in pharmacotherapy. Adv Psychiatr Treat 19:181–190
Guo W, Pang K, Chen Y, Wang S, Li H, Xu Y, Han F, Yao H, Liu H, Lopes-Rodrigues V, Sun D, Shao J, Shen J, Dou Y, Zhang W, You H, Wu W, Lu B (2019) TrkB agonistic antibodies superior to BDNF: Utility in treating motoneuron degeneration. Neurobiol Dis 132:104590
Article CAS PubMed Google Scholar
Harrell F Jr (2025) Hmisc: Harrell Miscellaneous. R package version 5.2-2. https://github.com/harrelfe/hmisc
Hori H, Kim Y (2019) Inflammation and post-traumatic stress disorder. Psychiatry Clin Neurosci 73:143–153
Johnston JN, Zarate CA, Kvarta MD (2024) Esketamine in depression: putative biomarkers from clinical research. European Archives of Psychiatry and Clinical Neuroscience
Kao CF, Liu YL, Yu YW, Yang AC, Lin E, Kuo PH, Tsai SJ (2018) Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients. Sci Rep 8:6983
Article PubMed PubMed Central Google Scholar
Klaeth JR, Jensen AG, Auren TJB, Solem S (2024) 12-month follow-up of intensive outpatient treatment for PTSD combining prolonged exposure therapy, EMDR and physical activity. BMC Psychiatry 24:225
Article PubMed PubMed Central Google Scholar
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace TW, Mercer KB, Mayberg HS, Bradley B, Nemeroff CB, Holsboer F, Heim CM, Ressler KJ, Rein T, Binder EB (2013) Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 16:33–41
Article CAS PubMed Google Scholar
Kumar R, Nunez NA, Joshi N, Joseph B, Verde A, Seshadri A, Cuellar Barboza AB, Prokop LJ, Medeiros GC, Singh B (2024) Metabolomic biomarkers for (R, S)-ketamine and (S)-ketamine in treatment-resistant depression and healthy controls: A systematic review. Bipolar Disord 26:321–330
Article CAS PubMed Google Scholar
Kuznetsova A, Brockhoff PB, Christensen RHB (2017) lmerTest Package: Tests in Linear Mixed Effects Models. J Stat Softw 82:1–26
Lesiak AJ, Coffey K, Cohen JH, Liang KJ, Chavkin C, Neumaier JF (2021) Sequencing the serotonergic neuron translatome reveals a new role for Fkbp5 in stress. Mol Psychiatry 26:4742–4753
Article CAS PubMed Google Scholar
Li H, Su P, Lai TK, Jiang A, Liu J, Zhai D, Campbell CT, Lee FH, Yong W, Pasricha S, Li S, Wong AH, Ressler KJ, Liu F (2020) The glucocorticoid receptor-FKBP51 complex contributes to fear conditioning and posttraumatic stress disorder. J Clin Invest 130:877–889
Article CAS PubMed PubMed Central Google Scholar
López-Ojeda W, Hurley RA (2022) Extended Reality Technologies: Expanding Therapeutic Approaches for PTSD. J Neuropsychiatry Clin Neurosci 34:A4–5
Lovibond SH, Lovibond PF (1995) Manual for the Depression Anxiety Stress Scales, 2nd edn. Psychology Foundation, Sydney
Mehta D, Gonik M, Klengel T, Rex-Haffner M, Menke A, Rubel J, Mercer KB, Putz B, Bradley B, Holsboer F, Ressler KJ, Muller-Myhsok B, Binder EB (2011) Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry 68:901–910
Article CAS PubMed PubMed Central Google Scholar
Michopoulos V, Norrholm SD, Jovanovic T (2015) Diagnostic biomarkers for posttraumatic stress disorder: Promising horizons from translational neuroscience research. Biol Psychiatry 78:344–353
Comments (0)